Studies have shown that in COPD GRB2, by activating the PI3K / AKT pathway, it increases the BCL-2 expression and prevents the apoptosis of airway epithelial cells (AECs) [48]. Here, BCL2 is linked to chronic obstructive pulmonary disease.